Cordypharm Biotech Private Limited
Founded in 2020 and headquartered in Telangana, India.
2020 | Hyderabad, Telangana (India) | Inactive
Cordypharm Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
About Cordypharm Biotech
Cordypharm Biotech Private Limited (CBPL) is Strike Off company established on 27 Oct 2020 with its office registered at Hyderabad, Telangana, India and has been running since 4 Year, 4 Months with a paid up capital of 0.10 M. According to MCA records, 4 Directors are linked to this company as of 03 Feb 2025.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01100TG2020PTC145290
- Company No.
145290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2020
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Agriculture
Who are the key members and board of directors at Cordypharm Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atik Patel  | Director | 27-Oct-2020 | Current |
| Parvin Jiwani | Director | 27-Oct-2020 | Current |
| Nuruddin Patel | Director | 27-Oct-2020 | Current |
| Amyn Patel | Director | 27-Oct-2020 | Current |
Financial Performance of Cordypharm Biotech.
Enhance accessibility to Cordypharm Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cordypharm Biotech?
Unlock access to Cordypharm Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Clone Deals Private LimitedParvin Jiwani and Nuruddin Patel are mutual person
- Lonestar Glass And Aluminium Llp
Nuruddin Patel is a mutual person
- Lonestar Woods Llp
Nuruddin Patel, Amyn Patel and 1 more are mutual person
- Ambrosiya Neo-Medicine Private Limited
Atik Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cordypharm Biotech?
Cordypharm Biotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cordypharm Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cordypharm Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.